These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetic study of fosfomycin and its bioavailability. Cadórniga R; Diaz Fierros M; Olay T Chemotherapy; 1977; 23 Suppl 1():159-74. PubMed ID: 832511 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic data on fosfomycin in underweight infants during the neonatal period. Molina MA; Olay T; Quero J Chemotherapy; 1977; 23 Suppl 1():217-22. PubMed ID: 832519 [TBL] [Abstract][Full Text] [Related]
5. Fosfomycin in patients subjected to periodic hemodialysis. Revert L; López J; Pons J; Olay T Chemotherapy; 1977; 23 Suppl 1():204-9. PubMed ID: 832517 [TBL] [Abstract][Full Text] [Related]
6. [The in-vitro activity of fosfomycin and its pharmacokinetics in subjects with integral renal function, with renal failure and undergoing peritoneal and extracorporeal dialytic treatment]. De Rosa F; Enrico P; Buoncristiani U; Frongillo R G Ital Chemioter; 1977; 23(2):75-80. PubMed ID: 606612 [No Abstract] [Full Text] [Related]
8. [Correlation of hematic, urinary and renal parenchymal fosfomycin concentrations]. Savoia D; Fontana G; Di Carlo R; Genazzani E G Ital Chemioter; 1977; 23(2):81-6. PubMed ID: 606613 [No Abstract] [Full Text] [Related]
9. Fosfomycin: Absorption and excretion. Shimizu K Chemotherapy; 1977; 23 Suppl 1():153-8. PubMed ID: 12926 [TBL] [Abstract][Full Text] [Related]
10. The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid. Fernandez Lastra C; Mariño EL; Dominguez-Gil A; Tabernero JM; Gonzalez Lopez A; Yuste Chaves M Eur J Clin Pharmacol; 1983; 25(3):333-8. PubMed ID: 6628521 [TBL] [Abstract][Full Text] [Related]
11. [Tissue levels of fosfomycin and tobramycin in the rat kidney]. Savoia D; Fontana G; Di Carlo R G Ital Chemioter; 1976; 23(1):9-10. PubMed ID: 1029697 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses. Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292 [TBL] [Abstract][Full Text] [Related]
13. Fosfomycin kinetics after intravenous and oral administration to human volunteers. Goto M; Sugiyama M; Nakajima S; Yamashina H Antimicrob Agents Chemother; 1981 Sep; 20(3):393-7. PubMed ID: 7305325 [TBL] [Abstract][Full Text] [Related]
14. [Levels of fosfomycin in the soft tissues of the oral cavity]. Menghini P; Sapelli PL; Ferrara A Minerva Med; 1978 Dec; 69(59):4135-7. PubMed ID: 740312 [No Abstract] [Full Text] [Related]
15. [Importance of fosfomycin urine and renal parenchyma levels in the treatment of urinary infections]. Asteriti M; Bellini G; Cartolari L; Zoni G Boll Chim Farm; 1978 Oct; 117(10):575-82. PubMed ID: 743353 [No Abstract] [Full Text] [Related]
16. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis. Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462 [TBL] [Abstract][Full Text] [Related]
17. [Fosfomycin, a new antibiotic drug (author's transl)]. Guggenbichler JP; Kienel G; Frisch H Padiatr Padol; 1978; 13(4):429-36. PubMed ID: 362351 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration. Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic study of Fosfomycin]. Wu PD; Yao SW; Zhang YY; Wang F Yao Xue Xue Bao; 1983 Apr; 18(4):247-50. PubMed ID: 6624467 [No Abstract] [Full Text] [Related]
20. Renal insufficiency and fosfomycin. Gobernado M; García J; Santos M; Panadero J; Diosdado N Chemotherapy; 1977; 23 Suppl 1():200-3. PubMed ID: 832516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]